research & development team broad agency announcement (baa) and other transaction authority...

Post on 14-Dec-2015

212 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

Research & Development Team Broad Agency Announcement (BAA) and

Other Transaction Authority (OTA)

OLAO-OA/COAC

Carolyn Keeseman

November 20, 2014

• 1 Branch Chief• 3 Contracting Officers• 3 Contract Specialists

• Awards/Actions• R & D contracts• Patent/Legal contracts• IT contracts• Lab maintenance contract• Acquisition Management Review contract

R & D Team

2

• NEI

• NINR

• NIGMS

• NIDCD

• OD And others to come . . .

R & D Team Customers

3

• CUSTOMER SERVICE!

R & D Team Focus

4

• Acquisition Plan drafted – over $500,000. Discuss exceptions with CO/CS

• SOW/SOO/PWS• Market Research • IGCE• 653 Funding Documenthttp://olao.od.nih.gov/office-acquisitions/COR-examples-and-templates• Plan to meet early with CO/CS – engage them in the

acquisition planning phase.

Requirements Package

5

• BAA solicitation posting for 1 year with cut-off dates (typically quarterly) for submission or open.

• First Stage: Submission and review of quad chart/white paper resulting in:

* An invitation to submit a full proposal * Notification of “do not invite”• Second Stage:

* Submission and review of full proposals

BAA process

6

• Purpose – Basic and applied research through FAR 35.016

• Describes the agency’s research areas of interest for individual program requirements,

• Describes criteria for selecting the proposals, their relative importance and evaluation method,

BAA Elements

7

• Specifies time periods for receipt of quad chart/white paper, and process for accepting full proposals, and

• Contains instructions for preparation and submission of proposals.

BAA Elements cont.

8

• Government is looking for answers to research areas of interest articulated in Statements of Work.

• Streamlines the procurement process.• Promotes the advancement of technology.• Allows for competition of ideas/concepts throughout

the established response period – 1 year.

Benefits of BAA

9

• Multiple submission periods possible.

• Can amend the BAA anytime to add or subtract information or requirements.

• Can remain open for up to a one year period of time. Each year thereafter consideration given for renewal if the need still exists.

Benefits of BAA cont.

10

• Focuses on scientific study and experimentation outlined in research and technical objectives.

• The Government drafts a statement of general research interest or a statement of the problem. The offerors draft their own statement of work and technical approach.

BAA Focus

11

• Proposals contain stand-alone unique solutions. They are not compared to one another.

• Each proposal presents a separate approach to solving the problem. There is technical competition in the marketplace of ideas; and this is what we hope to capture.

• The offeror is more engaged subsequent to the submission of a quad chart/white paper. Final evaluation is overall best value to the Government, past performance, and funding available.

BAA Proposals

12

• Proposals undergo a scientific review process. A proposal that is otherwise weak could be selected if it shows great technical promise or relevance to the NIH mission, such as a risky but perhaps revolutionary approach.

BAA evaluation

13

• Specific to R & D requirements. • Allows the Government to leverage commercial

investments and commercial technology.• Outside of the FAR / Provides flexibility to the

contracting process.• OTA is a legally binding, non-acquisition instrument

used to further advanced research and development.

Other Transaction Authority (OTA)

14

• Encourages consortium collaboration• Attracts firms that typically do not do business with

the Government• The OTA is a negotiated contract between the

Government and Vendor or Consortium arrangement

Other Transaction Authority (OTA) cont.

15

• BAA’s can solicit OTA’s.

Other Transaction Authority (OTA) cont.

16

• Stimulating Peripheral Activity to Relieve Conditions (SPARC)– Clinical utility of market-approved devices to support new

market indications within SPARC– Research on neural control and neuromodulation of organ

function to enable SPARC– Neuromodulation technology needs and challenges to

enable SPARC• Participants: NIDDK, NIBIB, NCATS and NINDS

OD BAA project

17

Proposed Initiatives

• Functional and anatomical mapping of five organ systems

• Next generation tools• Off-label use of existing market-approved technology

for small markets• Data coordination

OD BAA project cont.

18

Carolyn KeesemanOD/OALM/OLAO/OAR & D Branch Chief

301-496-8504Carolyn.Keeseman@nih.gov

Questions & Contact Information

19

top related